In a filing, Aileron Therapeutics Inc revealed its President and COO WINDSOR JAMES BRIAN acquired Company’s shares for reported $758.0 on Dec 15 ’23. In the deal valued at $3.37 per share,225 shares were bought. As a result of this transaction, WINDSOR JAMES BRIAN now holds 225 shares worth roughly $1203.75.
Then, WINDSOR JAMES BRIAN bought 5,076 shares, generating $9,987 in total proceeds. Upon buying the shares at $1.97, the President and COO now owns 5,122 shares.
William Blair initiated its Aileron Therapeutics Inc [ALRN] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. BofA/Merrill began covering ALRN with “Buy” recommendation on July 24, 2017.
Price Performance Review of ALRN
On Tuesday, Aileron Therapeutics Inc [NASDAQ:ALRN] saw its stock fall -9.78% to $5.35. Over the last five days, the stock has lost -9.17%. Aileron Therapeutics Inc shares have risen nearly 75.49% since the year began. Nevertheless, the stocks have risen 224.24% over the past one year. While a 52-week high of $7.12 was reached on 03/27/24, a 52-week low of $1.01 was recorded on 01/08/24. SMA at 50 days reached $5.35, while 200 days put it at $2.97. A total of 0.2 million shares were traded, compared to the trading of 15700.0 shares in the previous session.
Levels Of Support And Resistance For ALRN Stock
The 24-hour chart illustrates a support level at 5.00, which if violated will result in even more drops to 4.64. On the upside, there is a resistance level at 5.61. A further resistance level may holdings at 5.86. The Relative Strength Index (RSI) on the 14-day chart is 45.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 79.73%. Stochastics %K at 28.50% indicates the stock is a holding.
